Malgorzata A. Walicka

Array ( [id] => 5107957 [patent_doc_number] => 20070066835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Process for the synthesis of amorphous atorvastain calcium' [patent_app_type] => utility [patent_app_number] => 10/550415 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1701 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066835.pdf [firstpage_image] =>[orig_patent_app_number] => 10550415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860334 [patent_doc_number] => 20080269184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof' [patent_app_type] => utility [patent_app_number] => 10/591658 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7174 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269184.pdf [firstpage_image] =>[orig_patent_app_number] => 10591658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693764 [patent_doc_number] => 20070015922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Process for the preparation of 1,1,3,3-tetraalkylisoindoline starting from n-benzylphthalimide' [patent_app_type] => utility [patent_app_number] => 10/547382 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2153 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015922.pdf [firstpage_image] =>[orig_patent_app_number] => 10547382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687298 [patent_doc_number] => 20090176993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Calcium receptor active compounds' [patent_app_type] => utility [patent_app_number] => 10/389093 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 94 [patent_figures_cnt] => 94 [patent_no_of_words] => 115116 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176993.pdf [firstpage_image] =>[orig_patent_app_number] => 10389093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5160491 [patent_doc_number] => 20070173535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Oxadiazoles having antiproliferative activity' [patent_app_type] => utility [patent_app_number] => 11/596392 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4366 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173535.pdf [firstpage_image] =>[orig_patent_app_number] => 11596392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7142843 [patent_doc_number] => 20050118202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Solid compositions containing compounds unstable to oxygen and method for stabilization thereof' [patent_app_type] => utility [patent_app_number] => 10/498067 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14477 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118202.pdf [firstpage_image] =>[orig_patent_app_number] => 10498067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583508 [patent_doc_number] => 07851411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'α-Cyanoacrylates' [patent_app_type] => utility [patent_app_number] => 10/499522 [patent_app_country] => US [patent_app_date] => 2002-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21895 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851411.pdf [firstpage_image] =>[orig_patent_app_number] => 10499522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060521 [patent_doc_number] => 20050002881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Pigment dispersion for cosmetic' [patent_app_type] => utility [patent_app_number] => 10/497319 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3849 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002881.pdf [firstpage_image] =>[orig_patent_app_number] => 10497319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7024984 [patent_doc_number] => 20050019378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Transdermal drug delivery system of strychnine, brucine, securinine and their salts' [patent_app_type] => utility [patent_app_number] => 10/496309 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1041 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019378.pdf [firstpage_image] =>[orig_patent_app_number] => 10496309 [rel_patent_id] =>[rel_patent_doc_number] =>)